New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
14:51 EDTMDXGMiMedx addressed reimbursement fears on call, says Craig-Hallum
Craig-Hallum said MiMedx management outlined reimbursement scenarios for when the company no longer has pass-through status, calming the fears of some investors. Craig-Hallum also noted that the company raised the lower-end of its FY14 revenue guidance to $95M from $90M and that management said its meeting with the FDA about its micronized injectable products was both "productive and helpful." The firm reiterates its Buy rating and $10 price target on MiMedx.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
07:45 EDTMDXGMiMedx backs FY15 revenue $175M-$185M, consensus $180.57M
Subscribe for More Information
07:45 EDTMDXGMiMedx backs FY14 revenue to $116M-$117M, consensus $116.73M
07:44 EDTMDXGMiMedx backs Q4 revenue $37.3M-$38.3M, consensus $38.11M
Subscribe for More Information
07:43 EDTMDXGMiMedx reports Q1 EPS 3c, consensus 2c
Reports Q1 revenue $33.5M, consensus $33.5M
October 23, 2014
10:42 EDTMDXGHigh option volume stocks
High option volume stocks: ALIM ROC CAKE MDXG SMH CFX CRI INFN LTM
October 21, 2014
12:10 EDTMDXGMiMedx provides update on outstanding patent litigation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use